Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) Q2 2023 Earnings Call Transcript
Operator: Hello, and thank you for standing by. Welcome to Intercept Pharmaceuticals Second Quarter 2023 Earnings Conference Call.
Posts Tagged ‘NASDAQ:ICPT’
Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) Q4 2022 Earnings Call Transcript
Operator: Good day and thank you for standing by. Welcome to the Intercept Pharmaceuticals Fourth Quarter and Full Year 2022 Earnings Conference Call.
13 High Growth Pharma Stocks that are Profitable
One industry that has rapidly evolved with time and impacted millions, if not billions, of lives is the pharmaceutical sector.
10 Most Shorted Stocks to Watch in July
In this article, we discuss the 10 most shorted stocks to watch in July.
15 Biotech Stocks to Buy Now According to Srini Akkaraju and Michael Dybbs’ Samsara BioCapital
In this article, we will discuss 15 biotech stocks to buy now according to Srini Akkaraju and Michael Dybbs' Samsara BioCapital.
5 Best Short Squeeze Stocks To Buy Now
In this article, we discuss the 5 best short squeeze stocks to buy now.
Hedge Fund and Insider Trading News: Bill Ackman, Mike Novogratz, Sanjay Shah, LIOR Global Partners, Anomaly Capital, Two Sigma Investments, Intercept Pharmaceuticals Inc (ICPT), Kaiser Aluminum Corp. (KALU), and More
Billionaire investor Bill Ackman said Monday he donated his entire stake in Coupang - worth more than $1 billion - to charity following the South Korean e-commerce company’s...
5 Underperforming Stocks Targeted By Short Sellers
In this article we discuss top 5 underperforming stocks targeted by short sellers.
Is ICPT A Good Stock To Buy According To Hedge Funds?
At Insider Monkey, we pore over the filings of nearly 817 top investment firms every quarter, a process we have now completed for the latest reporting period.
Hedge Funds Slowly Coming Back To Intercept Pharmaceuticals Inc (ICPT)
The latest 13F reporting period has come and gone, and Insider Monkey have plowed through 823 13F filings that hedge funds and well-known value investors are required to file ...
Did Hedge Funds Make The Right Call On Intercept Pharmaceuticals Inc (ICPT)?
At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (see why hell is coming).
Is Intercept Pharmaceuticals Inc (ICPT) Going to Burn These Hedge Funds?
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Hedge Funds Have Never Been This Bullish On Intercept Pharmaceuticals Inc (ICPT)
We hate to say this but, we told you so.
Did Hedge Funds Drop The Ball On Intercept Pharmaceuticals Inc (ICPT) ?
Most investors tend to think that hedge funds and other asset managers are worthless, as they cannot beat even simple index fund portfolios.
Hedge Funds Have Never Been This Bullish On Intercept Pharmaceuticals Inc (ICPT)
Reputable billionaire investors such as Jim Simons, Cliff Asness and David Tepper generate exorbitant profits for their wealthy accredited investors (a minimum of $1 million in...
Hedge Fund and Insider Trading News: David Rich, Autonomy Capital, Third Point LLC, Intercept Pharmaceuticals Inc (ICPT), Procter & Gamble Co (PG), and More
Of all the billionaires, hedge fund managers and chief executives who have showered politicians in New York with money in the last five years, no one has given more often than...
Is Intercept Pharmaceuticals Inc (ICPT) A Good Stock To Buy?
"The end to the U.S. Government shutdown, reports of progress on China-U.S.
Here’s What Hedge Funds Think About Intercept Pharmaceuticals Inc (ICPT)
While the market driven by short-term sentiment influenced by uncertainty regarding the future of the interest rate environment in the US, declining oil prices and the trade war...
Hedge Funds Are Betting On Intercept Pharmaceuticals Inc (ICPT)
Investing in small cap stocks has historically been a way to outperform the market, as small cap companies typically grow faster on average than the blue chips.
Intercept Pharmaceuticals Inc (ICPT): Are Hedge Funds Right About This Stock?
Investing in hedge funds can bring large profits, but it’s not for everybody, since hedge funds are available only for high-net-worth individuals.
Investors Are Buzzing About These 5 Morning Movers
In contrast to yesterday's action, the major indexes are all green today, with crude futures leading the way, up by 5%.
Why Are These Stocks Among Today’s Losers?
This week's roller coaster is coming to and end with a bang, as U.S. stocks are deep in the red territory and the Dow is down by triple digits.
Why Are These Five Stocks Surging on Tuesday?
Seeing as all three indexes have surged more than 1% in morning trading as the Federal Reserve promises interest rates will still be low for a while, shares of Inland Real Estate...
Is Intercept Pharmaceuticals Inc (ICPT) A Good Stock To Buy?
After several tireless days we have finished crunching the numbers from the more than 700 13F filings issued by the elite hedge funds and other investment firms that we track ...
These Five Biotech Stocks Ranked Among This UK-based Fund’s Favorites
Cheyne Capital is one of the few non-U.S firms that we track in our database.
Esperion Therapeutics Inc (ESPR), Intercept Pharmaceuticals Inc (ICPT): Visium and OrbiMed’s Recent Activity in Biotech
Stocks in the biotechnology industry have been very active as of late, with companies' shares registering significant gains.
Healthcare Hedge Fund Orbimed’s Top Picks and New Move
According to a Schedule 13D form filed yesterday with the Securities and Exchange Commission, Samuel Islay's Orbimed Advisors has slashed its stake in Intercept Pharmaceuticals...
Applied Genetic Technologies Corp (AGTC): Steve Cohen Starts New Stake With 5.8% of The Company’s Outstanding Stock
Steve Cohen’s Point72 Asset Management disclosed today a new position in Applied Genetic Technologies Corp (NASDAQ:AGTC). The funds affiliated with Mr.
Intercept Pharmaceuticals Inc. (ICPT), Bristol-Myers Squibb Co (BMY), Biogen Idec Inc (BIIB): Orbimed Advisors Top Stocks in Q2
Orbimed Advisors, led by Samuel Isaly, recently published its 13F filing with the U.S. Securities and Exchange Commission.
Orbimed Advisors Further Cuts Exposure To Intercept Pharmaceuticals Inc. (ICPT)
Orbimed Advisors, led by Samuel Isaly, has disclosed cutting its position in Intercept Pharmaceuticals Inc. (NASDAQ:ICPT).
Intercept Pharmaceuticals Inc. (ICPT)’s Positive Liver Cure Overshadows Dismal Second Quarter Results
Intercept Pharmaceuticals Inc.
NASH a Big Opportunity For Gilead Sciences, Inc. (GILD)
After being a dominant player in the hepatitis C market with its drug Sovaldi, Gilead Sciences, Inc.
Triumph Group Inc (TGI), Intercept Pharmaceuticals Inc (ICPT), Zynga Inc (ZNGA): Viking Global’s Top 5 Small-Cap Picks
Small-cap picks from individual funds might provide investors with attractive investment options.
Orbimed Advisors Cuts Stake In Intercept Pharmaceuticals Inc (ICPT)
Orbimed Advisors is limiting exposure to Intercept Pharmaceuticals Inc (NASDAQ:ICPT), after selling approximately 81,305 shares in one transaction at $320 a piece, according...
Second Wave of Moves from SAC Capital
In another set of filing with the Securities and Exchange Commission, Steven Cohen and his fund, SAC Capital Advisors, have revealed a number of changes to their equity portfolio...
Visium Asset Management Ups Stake in Skyrocketing Intercept Pharmaceuticals Inc (ICPT)
Jacob Gottlieb's Visium Asset Management has increased its stake in Intercept Pharmaceuticals Inc (NASDAQ:ICPT), according to an amended filing with the SEC. Gottlieb's fund...
Steve Cohen, SAC Capital Reveal 5.3% Stake in Intercept Pharmaceuticals
Steve Cohen's SAC Capital has just revealed a 5.3% stake in Intercept Pharmaceuticals Inc (NASDAQ:ICPT), a new filing with the SEC indicates.
Samuel Isaly’s Orbimed Advisors Sells Some Intercept Pharmaceuticals Stock at $62.50/Share
Orbimed Advisors, Intercept Pharmaceuticals: Samuel Isaly and his hedge fund, Orbimed Advisors, is focused on healthcare stocks.
Orbimed Downgrades its Position in Intercept Pharmaceuticals
Orbimed Advisors, Intercept Pharmaceuticals: In a recent SEC filing, Samuel Isaly and his hedge fund, Orbimed Advisors, reported decreasing their holding in Intercept Pharmaceuticals...
Is Pacira Pharmaceuticals Inc (PCRX) Going to Burn These Hedge Funds?
To the average investor, there are many methods market participants can use to analyze publicly traded companies.
What Hedge Funds Think About Kythera Biopharmaceuticals Inc (KYTH)
To the average investor, there are tons of methods market participants can use to track publicly traded companies.
This Metric Says You Are Smart to Buy Neurocrine Biosciences, Inc. (NBIX)
In the financial world, there are dozens of indicators investors can use to track publicly traded companies. Two of the best are hedge fund and insider trading movement.
Hedge Funds Are Buying Impax Laboratories Inc (IPXL)
At the moment, there are tons of indicators shareholders can use to analyze publicly traded companies.
Hedge Funds Aren’t Crazy About Rigel Pharmaceuticals, Inc. (RIGL) Anymore
In the eyes of many investors, hedge funds are seen as useless, outdated investment tools of a forgotten age.
Is Aegerion Pharmaceuticals, Inc. (AEGR) Going to Burn These Hedge Funds?
To the average investor, there are dozens of gauges market participants can use to watch publicly traded companies.
Nektar Therapeutics (NKTR), Stemline Therapeutics Inc (STML): Humongous Health-Care Stocks This Week
While the market jittered this week over what the Federal Reserve will do next, some stocks didn't flinch.
Hedge Funds Are Buying Endocyte, Inc. (ECYT)
At the moment, there are plenty of metrics shareholders can use to watch Mr. Market. A pair of the best are hedge fund and insider trading activity.
Hedge Funds Are Betting On Kythera Biopharmaceuticals Inc (KYTH)
Kythera Biopharmaceuticals Inc (NASDAQ:KYTH) was in 10 hedge funds' portfolio at the end of March.
Here is What Hedge Funds Think About Pacira Pharmaceuticals Inc (PCRX)
Is Pacira Pharmaceuticals Inc (NASDAQ:PCRX) a superb investment right now? Hedge funds are in an optimistic mood.
Neurocrine Biosciences, Inc. (NBIX): Are Hedge Funds Right About This Stock?
Neurocrine Biosciences, Inc. (NASDAQ:NBIX) was in 16 hedge funds' portfolio at the end of the first quarter of 2013.
